Heart Failure with Recovered Ejection Fraction in Patients with Vinculin Loss-of-function Variants

Laura Zahavich1,2,3, Rajadurai Akilen4, Kristen George3

  • 1Department of Genetic Counselling, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Insights

Genetic variants in vinculin (VCL) may predict heart recovery in infants with dilated cardiomyopathy (DCM). Over 80% of infants with VCL loss-of-function variants showed improved heart function, suggesting a genetic basis for heart recovery.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Predicting myocardial recovery in heart failure (HF) remains challenging.
  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure in infants.
  • The genetic underpinnings of HF recovery are not well understood.

Purpose of the Study:

  • To investigate the association between vinculin (VCL) variants and myocardial recovery in infants with DCM.
  • To identify potential genetic predictors for HF recovery in pediatric populations.

Main Methods:

  • Case series analysis of six infants diagnosed with DCM and identified VCL loss-of-function (LOF) variants.
  • Evaluation of left ventricular (LV) ejection fraction (EF) and LV end-diastolic diameter z-score at diagnosis and during follow-up.
  • Assessment of response to standard HF medications.

Main Results:

  • Six infants with DCM and VCL LOF variants were identified, presenting with severely reduced LV ejection fraction (median 24%).
  • Despite initial severe HF, 83% of patients demonstrated normalization of LV function by a median age of 2.7 years.
  • One patient experienced disease progression requiring heart transplantation.

Conclusions:

  • Loss-of-function variants in the VCL gene are associated with a unique phenotype of DCM in infants.
  • A significant proportion of these patients exhibit spontaneous recovery of left ventricular function, suggesting a genetic basis for heart failure with recovered ejection fraction.
  • These findings have important prognostic implications for genetic counseling and clinical management of VCL-associated DCM.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19